White Paper

Developing Advanced Therapies: Considerations For Internal Versus External Manufacturing

Vial drug development.jpg

Due to their complexity and cost, developers of cell and gene therapies face unique manufacturing hurdles. Determining the right approach to manufacturing is crucial when bringing these advanced therapeutics from clinical to commercialization. Recently, Precision for Medicine co- sponsored a webinar with Informa Pharma Intelligence, bringing together high-profile leaders in the cell and gene therapy space to discuss key considerations for cell and gene therapies. The combined expertise of these four panelists in their respective fields of investment management; manufacturing and technical operations; global pricing; and commercialization, advocacy, and legislation provided a distinctive perspective on how to approach manufacturing and other roadblocks at every stage of development.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene